an increased insulin dose may be needed, which should be undertaken carefully to minimise the risk of hypoglycaemia or hyperglycaemia. after stopping dapagliflozin treatment, frequent blood glucose monitoring is recommended.dapagliflozin should be reviewed and discontinued in patients with type 1 diabetes by or in consultation with a physician specialised in diabetes care as soon as clinically practical.
0 Comments
Leave a Reply. |